Accepted Manuscripts
-
Therapeutics to harness the immune microenvironment in multiple myeloma
Review |Published on: 7 May 2022 -
Multicellular biomarkers of drug resistance as promising targets for glioma precision medicine and predictors of patient survival
Original Article |Published on: 20 Apr 2022
See more
Articles
-
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response
Review|Published on: 12 May 2022 -
RIP140 regulates POLK gene expression and the response to alkylating drugs in colon cancer cells
Original Article|Published on: 7 May 2022 -
Venetoclax resistance: mechanistic insights and future strategies
Review|Published on: 6 May 2022 -
DNA damage and metabolic mechanisms of cancer drug resistance
Review|Published on: 5 May 2022
See more
Most Cited Papers In Last Two Years
-
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Review|Published on: 19 Mar 2021 -
Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
Review|Published on: 19 Mar 2020 -
Drug resistance in glioblastoma: are persisters the key to therapy?
Review|Published on: 7 Aug 2020 -
Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer
Review|Published on: 19 Mar 2020
See more
About The Journal
-
ISSN
2578-532X (Online)
Publisher
OAE Publishing Inc.
Article Processing Charges
$1200
-
Editor-in-Chief
Godefridus J. Peters
Publishing Model
Gold Open Access
Copyright
Copyright is retained by author(s)
-
Publication Frequency
Quarterly
Indexing
Open Archives
-
Portico
All published articles will be preserved here permanently:
https://www.portico.org/publishers/oae/